Experience: 32mg 2C-B - Bromo Mescaline: Difference between revisions

Line 13:

The setting for the experience was a basement room with white walls and no windows, with comfortable furniture and a computer desk. On the computer monitors there appeared a slideshow of fine art paintings and drawings, changing every two minutes. Most of the experience occurred in a pregnant silence.

Before taking the ~~Bromo Mescaline~~ dose, T and B shared approximately 0.5 g of vaporized cannabis hash at a friend's house at 1005. T and B then moved to T's muted basement, where 50 mg of ~~Bromo Mescaline~~ was weighed out on a milligram scale that was determined to be accurate to +/- 3 mg. They then dissolved the solid into 50 mL tap water. The solubility was very good at this density. Using a volumetric pipette the solution was split into two vials, 25 mL each.

Before taking the 2C-B dose, T and B shared approximately 0.5 g of vaporized cannabis hash at a friend's house at 1005. T and B then moved to T's muted basement, where 50 mg of 2C-B was weighed out on a milligram scale that was determined to be accurate to +/- 3 mg. They then dissolved the solid into 50 mL tap water. The solubility was very good at this density. Using a volumetric pipette the solution was split into two vials, 25 mL each.

At 1045, T and B orally ingested 25 mg ~~Bromo Mescaline~~ by drinking the contents of vials.

At 1045, T and B orally ingested 25 mg 2C-B by drinking the contents of vials.

At 1058, B perceived a change described as an increase in energy. B noted that he was concerned about how ~~Bromo Mescaline~~ would interact with his memory of a traumatic fracture in his arm sustained from an automobile accident. In B's first experience, he was forced to revisit the feeling and memory of that fracture, which manifested in the arm opposite the actual injury. This was an uncomfortable experience for B. He related to Shulgin's comment at Bromo Mescaline’s entry in PiHKAL, "There are people who choose not to go into the corporeal but, rather, prefer the out-of-body experience." B was apprehensive not knowing if the 'physical memory' he had experienced the first time would take over the experience once again.

At 1058, B perceived a change described as an increase in energy. B noted that he was concerned about how 2C-B would interact with his memory of a traumatic fracture in his arm sustained from an automobile accident. In B's first experience, he was forced to revisit the feeling and memory of that fracture, which manifested in the arm opposite the actual injury. This was an uncomfortable experience for B. He related to Shulgin's comment at Bromo Mescaline’s entry in PiHKAL, "There are people who choose not to go into the corporeal but, rather, prefer the out-of-body experience." B was apprehensive not knowing if the 'physical memory' he had experienced the first time would take over the experience once again.

At 1109, B walked to the bathroom and while there noticed moving shadows and subtle lines in the periphery of his vision, which he described as "echoy waves." At the same time, T is noticing undulation in the pattern of the carpet and an intensification of the light emitted from the computer monitors and ceiling lighting fixtures.

At 1115, all lights were turned down save for what T described as brilliant and intense colors emitted from the computer monitors. T felt that this change facilitated a greater focus on ~~Bromo Mescaline~~'s effects.

At 1115, all lights were turned down save for what T described as brilliant and intense colors emitted from the computer monitors. T felt that this change facilitated a greater focus on 2C-B's effects.

At 1118, B reported tinnitus, severe in his right ear and mild in the left.

Line 45:

At 1353, it was noted that conversation continued in a lucid manner, although T noted difficulty maintaining a linear focus.

At 1445, (T+4 hours) T and B repeated the volumetric dosing procedure described above, this time weighing out 14 mg ~~Bromo Mescaline~~ and resulting in a supplemental dose of 7 mg. They then each took 100 mg 5-HTP to maintain serotonin production and promote positive sleep and a softer landing coming off the ~~Bromo Mescaline~~.

At 1445, (T+4 hours) T and B repeated the volumetric dosing procedure described above, this time weighing out 14 mg 2C-B and resulting in a supplemental dose of 7 mg. They then each took 100 mg 5-HTP to maintain serotonin production and promote positive sleep and a softer landing coming off the 2C-B.

At 1500, T and B continued used of cannabis and a nicotine vaporizer. The effects, according to T, were mildly synergistic. They discontinued use of the vaporizer after a few hits, preferring to not distort the ~~Bromo Mescaline~~ effects any further.

At 1500, T and B continued used of cannabis and a nicotine vaporizer. The effects, according to T, were mildly synergistic. They discontinued use of the vaporizer after a few hits, preferring to not distort the 2C-B effects any further.

Shortly after, B said he was able to resolve/reconcile the memory of the impact fracture, which played an important part of the previous ~~Bromo Mescaline~~ experience. In his second experience, at a higher dose and with cannabis, the memory of the impact fracture was not present.

Shortly after, B said he was able to resolve/reconcile the memory of the impact fracture, which played an important part of the previous 2C-B experience. In his second experience, at a higher dose and with cannabis, the memory of the impact fracture was not present.

T's observation was that the 5-HTP resulted in a pleasant sleep, which was effortless at 1800. He woke up renewed and refreshed the following day.

@@ Line 13: / Line 13: @@
 The setting for the experience was a basement room with white walls and no windows, with comfortable furniture and a computer desk. On the computer monitors there appeared a slideshow of fine art paintings and drawings, changing every two minutes. Most of the experience occurred in a pregnant silence.
-Before taking the Bromo Mescaline dose, T and B shared approximately 0.5 g of vaporized cannabis hash at a friend's house at 1005. T and B then moved to T's muted basement, where 50 mg of Bromo Mescaline was weighed out on a milligram scale that was determined to be accurate to +/- 3 mg. They then dissolved the solid into 50 mL tap water. The solubility was very good at this density. Using a volumetric pipette the solution was split into two vials, 25 mL each.
+Before taking the 2C-B dose, T and B shared approximately 0.5 g of vaporized cannabis hash at a friend's house at 1005. T and B then moved to T's muted basement, where 50 mg of 2C-B was weighed out on a milligram scale that was determined to be accurate to +/- 3 mg. They then dissolved the solid into 50 mL tap water. The solubility was very good at this density. Using a volumetric pipette the solution was split into two vials, 25 mL each.
-At 1045, T and B orally ingested 25 mg Bromo Mescaline by drinking the contents of vials.
+At 1045, T and B orally ingested 25 mg 2C-B by drinking the contents of vials.
-At 1058, B perceived a change described as an increase in energy. B noted that he was concerned about how Bromo Mescaline would interact with his memory of a traumatic fracture in his arm sustained from an automobile accident. In B's first experience, he was forced to revisit the feeling and memory of that fracture, which manifested in the arm opposite the actual injury. This was an uncomfortable experience for B. He related to Shulgin's comment at Bromo Mescaline’s entry in PiHKAL, "There are people who choose not to go into the corporeal but, rather, prefer the out-of-body experience." B was apprehensive not knowing if the 'physical memory' he had experienced the first time would take over the experience once again.
+At 1058, B perceived a change described as an increase in energy. B noted that he was concerned about how 2C-B would interact with his memory of a traumatic fracture in his arm sustained from an automobile accident. In B's first experience, he was forced to revisit the feeling and memory of that fracture, which manifested in the arm opposite the actual injury. This was an uncomfortable experience for B. He related to Shulgin's comment at Bromo Mescaline’s entry in PiHKAL, "There are people who choose not to go into the corporeal but, rather, prefer the out-of-body experience." B was apprehensive not knowing if the 'physical memory' he had experienced the first time would take over the experience once again.
 At 1109, B walked to the bathroom and while there noticed moving shadows and subtle lines in the periphery of his vision, which he described as "echoy waves." At the same time, T is noticing undulation in the pattern of the carpet and an intensification of the light emitted from the computer monitors and ceiling lighting fixtures.
-At 1115, all lights were turned down save for what T described as brilliant and intense colors emitted from the computer monitors. T felt that this change facilitated a greater focus on Bromo Mescaline's effects.
+At 1115, all lights were turned down save for what T described as brilliant and intense colors emitted from the computer monitors. T felt that this change facilitated a greater focus on 2C-B's effects.
 At 1118, B reported tinnitus, severe in his right ear and mild in the left.
@@ Line 45: / Line 45: @@
 At 1353, it was noted that conversation continued in a lucid manner, although T noted difficulty maintaining a linear focus.
-At 1445, (T+4 hours) T and B repeated the volumetric dosing procedure described above, this time weighing out 14 mg Bromo Mescaline and resulting in a supplemental dose of 7 mg. They then each took 100 mg 5-HTP to maintain serotonin production and promote positive sleep and a softer landing coming off the Bromo Mescaline.
+At 1445, (T+4 hours) T and B repeated the volumetric dosing procedure described above, this time weighing out 14 mg 2C-B and resulting in a supplemental dose of 7 mg. They then each took 100 mg 5-HTP to maintain serotonin production and promote positive sleep and a softer landing coming off the 2C-B.
-At 1500, T and B continued used of cannabis and a nicotine vaporizer. The effects, according to T, were mildly synergistic. They discontinued use of the vaporizer after a few hits, preferring to not distort the Bromo Mescaline effects any further.
+At 1500, T and B continued used of cannabis and a nicotine vaporizer. The effects, according to T, were mildly synergistic. They discontinued use of the vaporizer after a few hits, preferring to not distort the 2C-B effects any further.
-Shortly after, B said he was able to resolve/reconcile the memory of the impact fracture, which played an important part of the previous Bromo Mescaline experience. In his second experience, at a higher dose and with cannabis, the memory of the impact fracture was not present.
+Shortly after, B said he was able to resolve/reconcile the memory of the impact fracture, which played an important part of the previous 2C-B experience. In his second experience, at a higher dose and with cannabis, the memory of the impact fracture was not present.
 T's observation was that the 5-HTP resulted in a pleasant sleep, which was effortless at 1800. He woke up renewed and refreshed the following day.